Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-2-Fluoro-p-hydroxycinnamic acid | - |
Sus scrofa | |
(E)-2-Fluorocinnamic acid | - |
Sus scrofa | |
(E)-cinnamic acid | - |
Sus scrofa | |
(E)-p-hydroxycinnamic acid | - |
Sus scrofa | |
(p-Hydroxybenzylidene)malonate | - |
Sus scrofa | |
(Z)-2-Fluorocinnamic acid | - |
Sus scrofa | |
(Z)-cinnamic acid | - |
Sus scrofa | |
(Z)-Fluoro-p-hydroxycinnamic acid | - |
Sus scrofa | |
(Z)-p-hydroxycinnamic acid | - |
Sus scrofa |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.072 | - |
(4-hydroxyphenyl)pyruvate | enol-form, kidney | Sus scrofa | |
2.2 | - |
(4-hydroxyphenyl)pyruvate | keto-form, kidney | Sus scrofa | |
6.1 | - |
phenylpyruvate | keto-form, kidney | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
kidney | - |
Sus scrofa | - |
thyroid gland | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(Diiodohydroxyphenyl)pyruvate | keto-form | Sus scrofa | ? | - |
? | |
3-(4-hydroxyphenyl)pyruvate | keto-form | Sus scrofa | 2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoate | enol-form | ? | |
Phenylpyruvate | r | Sus scrofa | Phenylpyruvate | - |
? | |
Phenylpyruvate | keto-form | Sus scrofa | Phenylpyruvate | - |
? |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.052 | - |
(4-hydroxyphenyl)pyruvate | enol-form, kidney | Sus scrofa | |
0.45 | - |
phenylpyruvate | keto-form, kidney | Sus scrofa | |
1.89 | - |
(4-hydroxyphenyl)pyruvate | keto-form, kidney | Sus scrofa |